Pigmentation-pathway peptide compounds.

Tanning and pigmentation research peptides are melanocortin receptor agonists (alpha-MSH analogs) studied in preclinical research models for their effects on melanogenesis signaling. The Nexus catalog includes 2 compounds in this category — examples: MT-1, MT-2 (Melanotan 2 Acetate). Supplied for in-vitro research use only with batch-level certificates of analysis.

The tanning and pigmentation category contains melanocortin-pathway research products. Nexus keeps this compact group separate from cosmetic and skin peptides because receptor context and buyer search behavior are different.

The category includes MT-1 and MT-2 / Melanotan 2. Copy remains research-grade and does not provide consumer-use guidance, dosage advice, or appearance claims.

Melanocortin research products are often compared by analog identity, receptor pathway, and structural differences. Because the category is small, the page prioritizes fast discovery and clean internal links rather than broad educational claims.

Nexus product pages keep the emphasis on variant size, COA context, and research-only positioning. This helps prevent cosmetic or personal-use interpretation while still allowing search engines to understand the catalog grouping.

Nexus uses conservative labeling, lab-verification context, and product-specific pages for each melanocortin record. Final COA and lot records should be checked before publishing launch inventory.

Compounds in this category are studied in preclinical research models examining the melanocortin pathway — particularly melanocortin-1 receptor (MC1R) pharmacology for pigmentation research and melanocortin-3/4 receptor pharmacology for broader research applications. Common research applications include MT-1 (Nle4-DPhe7-α-MSH / melanotan I / afamelanotide research analog) research on MC1R agonism, and MT-2 (melanotan II) research as a broader melanocortin agonist with activity across MC1R, MC3R, MC4R, and MC5R.

The two compounds in this category are both α-MSH analogs but differ in receptor selectivity: MT-1 is the more selective MC1R-focused research analog; MT-2 is the broader melanocortin agonist with multi-receptor activity. The structural difference is small (a cyclized variant in MT-2 versus the linear MT-1) but produces meaningful research-context differences in receptor pharmacology.

Common research-stack pairings cross the melanocortin family across categories: MT-1 and MT-2 paired with PT-141 (bremelanotide) in the Sexual Health category to compare melanocortin selectivity profiles, and paired with KPV (in Healing & Recovery) as a non-tanning melanocortin-pathway research peptide.

MT-1 and MT-2 are small peptides (~1.6-1.7 kDa) characterized by standard reverse-phase HPLC and ESI-MS. MT-2 is cyclized; cyclization is confirmed by molecular mass (the cyclized form has a different mass than the linear precursor).